Tzu-yin Cindy Lin is a highly experienced Research Associate Professor at the University of California, Davis, with a strong background in veterinary oncology and pathology. Tzu-yin has played a crucial role in interdisciplinary teams, contributing to the successful acquisition of an Investigational New Drug (IND) and the ongoing multi-center clinical trial. Tzu-yin's experience includes being a Paul Calabresi Clinical Oncology K12 Career Development Award recipient and serving as a Post-doctoral Researcher. As the Founder and Chief Operating Officer of Theranostec Inc, Tzu-yin has led initiatives to commercialize theranostic products, and as the Founder of iCLinpath, Tzu-yin provides real-time global cytology diagnostic services. Previous roles include Senior Principal Investigator at LP Therapeutics, where Tzu-yin led projects to develop nanoparticles for leukemia treatment, as well as a Veterinary Clinical Pathology Resident and Research Fellow at The Ohio State University. Tzu-yin holds a PhD in Veterinary Oncology and Pathology from The Ohio State University and a Doctor of Veterinary Medicine degree from National Taiwan University.
This person is not in the org chart